Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings

Bibliographic Details
Title: Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings
Authors: Blauvelt, Andrew, Shi, Nianwen, Somani, Najwa, Burge, Russel, Zhu, Baojin, Ridenour, Terri L., Lew, Carolyn R., Zimmerman, Nicole M., Atiya, Bilal, Murage, Mwangi J.
Source: In Journal of the American Academy of Dermatology March 2022 86(3):581-589
Database: ScienceDirect
More Details
ISSN:01909622
DOI:10.1016/j.jaad.2021.06.878
Published in:Journal of the American Academy of Dermatology
Language:English